trinitrobenzenesulfonic acid has been researched along with Edema in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Antonielli, LF; Arunachalam, K; Damazo, AS; Duckworth, CA; Lima, JCDS; Martins, DTO; Miyajima, F; Oliveira, RG; Pavan, E | 1 |
| Conner, EM; Reglinski, J; Smith, WE; Zeitlin, IJ | 1 |
| Algieri, F; Casares-Porcel, M; Del Mar Contreras, M; Diaz, C; Galvez, J; Garrido-Mesa, J; Garrido-Mesa, N; González-Tejero, MR; Molero-Mesa, J; Pérez-Palacio, J; Rodriguez-Cabezas, ME; Rodriguez-Nogales, A; Segura-Carretero, A; Utrilla, MP; Vergara, N; Vezza, T; Vicente, F | 1 |
| Guo, Z; Li, C; Li, Q; Li, Y; Liu, L; Long, Y; Mei, Q; Niu, Y; Sun, Y; Wang, Y; Wu, H; Zhang, M | 1 |
| Adams, MR; Bhargava, A; Brooks, JH; Chang, J; Clifton, MS; Hasdemir, B; Liao, M | 1 |
| Chen, G; Dou, Y; Guo, R; Han, G; Li, X; Li, Y; Shen, B; Shi, Y; Wang, H; Wang, L; Wang, R; Wang, Y; Xiao, H; Yang, Y | 1 |
| Cotterell, AJ; Do, AT; Fairlie, DP; Liu, L; Lohman, RJ; Suen, J; Vesey, DA | 1 |
| Chen, XC; Xu, Q | 1 |
| Arumugam, TV; Fairlie, DP; Reid, RC; Shiels, IA; Taylor, SM; Woodruff, TM | 1 |
| Arumugam, TV; Fairlie, DP; Newman, ML; Reid, RC; Ross, PA; Shiels, IA; Taylor, SM; Woodruff, TM | 1 |
| Mahadevan, IB; Manthey, HD; Pollitt, S; Proctor, LM; Shiels, IA; Stocks, SZ; Taylor, SM; Williams, HM; Woodruff, TM | 1 |
| Bae, CS; Jang, JS; Jo, SK; Jung, U; Kim, JC; Kim, SH; Kim, SR; Lee, HJ; Park, HR | 1 |
1 trial(s) available for trinitrobenzenesulfonic acid and Edema
| Article | Year |
|---|---|
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease.
Topics: Animals; Antibodies, Monoclonal; Body Weight; Colon; Disease Models, Animal; Eating; Edema; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Peptides, Cyclic; Peroxidase; Prednisolone; Rats; Rats, Wistar; Receptor, Anaphylatoxin C5a; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2003 |
11 other study(ies) available for trinitrobenzenesulfonic acid and Edema
| Article | Year |
|---|---|
Dilodendron bipinnatum Radlk. extract alleviates ulcerative colitis induced by TNBS in rats by reducing inflammatory cell infiltration, TNF-α and IL-1β concentrations, IL-17 and COX-2 expressions, supporting mucus production and promotes an antioxidant ef
Topics: Animals; Antioxidants; Brazil; Caco-2 Cells; Cell Survival; Colitis, Ulcerative; Cyclooxygenase 2; Disease Models, Animal; Edema; Glutathione; Humans; Interleukin-17; Interleukin-1beta; Interleukin-8; Lipopolysaccharides; Mast Cells; Mucus; Peroxidase; Plant Bark; Plant Extracts; Rats, Wistar; Sapindaceae; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2021 |
Schiff base complexes of copper and zinc as potential anti-colitic compounds.
Topics: Animals; Colitis; Copper; Edema; Hydrogen-Ion Concentration; Inflammation; Male; Mice; Molecular Structure; Organometallic Compounds; Rats; Rats, Wistar; Schiff Bases; Trinitrobenzenesulfonic Acid; Zinc | 2017 |
Anti-inflammatory activity of hydroalcoholic extracts of Lavandula dentata L. and Lavandula stoechas L.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Cell Line; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Colitis; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Edema; Female; Glutathione; Inflammation Mediators; Lavandula; Matrix Metalloproteinase 9; Methanol; Mice, Inbred BALB C; Neutrophil Infiltration; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Peroxidase; Phytotherapy; Plant Components, Aerial; Plant Extracts; Plants, Medicinal; Rats, Wistar; Solvents; Trinitrobenzenesulfonic Acid | 2016 |
Evidence for the complementary and synergistic effects of the three-alkaloid combination regimen containing berberine, hypaconitine and skimmianine on the ulcerative colitis rats induced by trinitrobenzene-sulfonic acid.
Topics: Acetic Acid; Aconitine; Alkaloids; Analgesics; Animals; Antidiarrheals; Behavior, Animal; Berberine; Colitis, Ulcerative; Colon; Drug Evaluation, Preclinical; Drug Synergism; Edema; Epithelial Cells; Gastrointestinal Transit; HT29 Cells; Humans; Inflammation; Male; Mice; NF-kappa B; Prunus; Quinolines; Rats; Toll-Like Receptor 4; Trinitrobenzenesulfonic Acid; Xylenes | 2011 |
Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2.
Topics: Animals; Blotting, Western; Colitis; Disease Progression; Edema; Extracellular Signal-Regulated MAP Kinases; Immunohistochemistry; Kinetics; Male; Peroxidase; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Signal Transduction; Trinitrobenzenesulfonic Acid; Urocortins | 2011 |
Colitogenic role of tumour necrosis factor (TNF) receptors in trinitrobenzene sulphonic acid colitis: TNF-R1 ablation does not affect systemic inflammatory response.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Body Weight; Chemokines; Colitis, Ulcerative; Colon; Cytokines; Edema; Gene Expression; Granulocytes; I-kappa B Proteins; Inflammation; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Monocytes; Neutrophils; NF-KappaB Inhibitor alpha; Organ Size; Peroxidase; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Spleen; Survival Analysis; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2011 |
Antagonism of protease-activated receptor 2 protects against experimental colitis.
Topics: Animals; Body Weight; Calcium Signaling; Colitis; Colon; Cytokines; Edema; HT29 Cells; Humans; Indenes; Intestinal Mucosa; Male; Oligopeptides; Piperazines; Piperidines; Rats; Rats, Wistar; Receptor, PAR-2; Sulfasalazine; Survival Rate; Transendothelial and Transepithelial Migration; Trinitrobenzenesulfonic Acid; Tryptases; Ulcer | 2012 |
CD4 T lymphocytes cause hepatocyte apoptosis by releasing Th1 cytokines in cellular immunological liver injury.
Topics: Animals; Apoptosis; CD4-Positive T-Lymphocytes; Chemical and Drug Induced Liver Injury; Cyclosporine; Ear Diseases; Edema; Female; Hepatocytes; Immunity, Cellular; Immunosuppressive Agents; Interleukin-2; Liver Diseases; Mice; Mice, Inbred BALB C; Picryl Chloride; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2002 |
A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis.
Topics: Animals; Body Weight; Colitis; Disease Models, Animal; Eating; Edema; Enzyme Inhibitors; Female; Group II Phospholipases A2; Humans; Hypertension; Inflammatory Bowel Diseases; Lipopolysaccharides; Neutropenia; Pentanoic Acids; Peroxidase; Phospholipases A; Phospholipases A2; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2005 |
Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease.
Topics: Animals; Biological Availability; Biotransformation; Complement C5a; Digestive System; Eating; Edema; Female; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Peptides, Cyclic; Rats; Rats, Wistar; Receptors, Complement; Trinitrobenzenesulfonic Acid; Ulcer; Weight Loss | 2005 |
Antiinflammatory activity of an herbal preparation (HemoHIM) in rats.
Topics: Administration, Oral; Angelica; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cnidium; Colitis; Cotton Fiber; Edema; Granuloma, Foreign-Body; Male; Paeonia; Phytotherapy; Plant Preparations; Plant Roots; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Rhizome; Trinitrobenzenesulfonic Acid | 2007 |